Discover the top 25 companies transforming the lateral flow assays market, including Abbott, Roche, Danaher, and other industry leaders. Backed by a market projected to grow from $8.51B to $12.52B by 2030 at a CAGR of 8.0%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping the future of the industry. Access the full market research report for deeper insights.

Download PDF Brochure:“Click Here”

Spotlights on the Industry’s Top Lateral Flow Assays Companies

Abbott Laboratories

Abbott Laboratories is a global healthcare leader that operates a diversified portfolio across diagnostics, medical devices, nutritionals, and branded generic medicines. Within the lateral flow assays market, the company is highly regarded for its rapid diagnostic platforms, such as the BinaxNOW COVID-19 Ag Card and ID NOW molecular system, which provide fast and reliable results at the point of care. Leveraging over 130 years of innovation and an extensive global distribution network, Abbott focuses on advancing decentralised testing to improve patient outcomes in infectious diseases, cardiology, and metabolic health.

F. Hoffmann-La Roche Ltd.

F. Hoffmann-La Roche Ltd. is a dominant Swiss multinational healthcare company and a world leader in in vitro diagnostics (IVD). Through its Roche Diagnostics division, the company offers a broad range of high-performance lateral flow solutions, including rapid antigen tests for respiratory viruses and point-of-care panels for cardiac biomarkers. Roche’s strategic emphasis on personalized healthcare and digital integration ensures that its diagnostic tools provide actionable medical insights, helping healthcare providers streamline workflows and make faster clinical decisions across more than 100 countries.

QuidelOrtho Corporation

QuidelOrtho Corporation is a premier global provider of innovative in vitro diagnostic technologies, formed by the merger of Quidel Corporation and Ortho Clinical Diagnostics. The company is a pioneer in women’s health and infectious disease testing, maintaining a market-leading position in the lateral flow segment with its well-known QuickVue and Sofia brands. By combining sophisticated immunoassay expertise with a vast global footprint in labs and point-of-care settings, QuidelOrtho delivers scalable diagnostic solutions that address critical needs in respiratory health, toxicology, and transfusion medicine.

Danaher Corporation

Danaher Corporation is a global science and technology innovator that maintains a significant presence in the diagnostics industry through its portfolio companies, such as Cepheid and Beckman Coulter. Danaher provides essential tools and consumables for lateral flow assay development and manufacturing, focusing on high-accuracy testing for hospital and clinical laboratory environments. The company’s commitment to operational excellence and the Danaher Business System (DBS) drives continuous innovation in automated diagnostic platforms and rapid testing technologies, supporting better patient management worldwide.

Siemens AG

Siemens AG, primarily through its Siemens Healthineers AG subsidiary, is a leading provider of medical imaging and laboratory diagnostics. In the lateral flow assays market, the company offers a comprehensive range of point-of-care testing solutions, including the CLINITEST Rapid COVID-19 Antigen Test. Siemens Healthineers leverages advanced automation and AI-driven informatics to bridge the gap between central laboratories and decentralized care settings, providing healthcare professionals with reliable, high-speed diagnostic tools to manage chronic and infectious diseases effectively.

Becton, Dickinson and Company

Becton, Dickinson and Company (BD) is a global medical technology firm that improves health by advancing medical discovery, diagnostics, and the delivery of care. BD is a major player in the lateral flow market with its BD Veritor Plus System, a digital handheld platform used for the rapid detection of various pathogens, including SARS-CoV-2 and influenza. By focusing on smart, connected diagnostic solutions, BD enables clinicians to perform high-quality testing in diverse settings, from retail clinics to emergency departments, enhancing the speed and accuracy of patient diagnosis.

BioMérieux SA

BioMérieux SA is a world leader in the field of in vitro diagnostics for infectious diseases, with a strong focus on clinical and industrial applications. The company’s diagnostic solutions include a variety of rapid tests and immunoassay systems designed to provide fast and accurate results for critical pathogens. BioMérieux’s expertise in microbiology and its commitment to public health drive the development of innovative lateral flow products that help clinicians optimize antibiotic therapy and control the spread of healthcare-associated infections.

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. is a global leader in serving science, providing a vast array of life sciences solutions, analytical instruments, and diagnostic tools. In the lateral flow space, the company provides high-quality raw materials, reagents, and contract manufacturing services for assay developers, as well as its own line of rapid diagnostic kits. Thermo Fisher’s massive R&D capacity and global supply chain support the rapid deployment of diagnostic tests at scale, ensuring healthcare providers have access to the essential tools needed for routine screening and outbreak response.

PerkinElmer Inc.

PerkinElmer Inc. is a specialized technology provider focused on innovating for a healthier world through advanced diagnostics and life sciences research. The company offers a diverse range of lateral flow assay solutions, particularly in the areas of neonatal screening, food safety, and infectious disease testing. PerkinElmer’s focus on high-sensitivity detection technologies and automated workflows empowers laboratories to deliver precise results, supporting early disease detection and the proactive management of global health challenges.

Qiagen N.V.

Qiagen N.V. is a global leader in Sample to Insight solutions that transform biological materials into valuable molecular insights. While primarily known for its molecular diagnostics and PCR platforms, Qiagen also provides specialized rapid testing solutions and reagents that support lateral flow assay development. The company’s strategic focus on infectious disease management and oncology diagnostics ensures that its technologies play a vital role in both clinical research and frontline patient care, facilitating the transition toward precision medicine.

Merck KGaA

Merck KGaA is a leading science and technology company that operates in life sciences, healthcare, and electronics. Through its Life Science business, Merck provides a comprehensive portfolio of high-quality raw materials for lateral flow assays, including nitrocellulose membranes, antibodies, and gold nanoparticles. As a critical supplier to the global diagnostics industry, Merck’s expertise in membrane technology and assay components enables manufacturers to develop robust, reliable, and sensitive rapid tests for a wide range of clinical and industrial applications.

Hologic, Inc.

Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. The company is a leader in molecular diagnostics and provides a variety of rapid testing solutions for women’s health, including assays for sexually transmitted infections and prenatal screening. Hologic’s commitment to clinical excellence and its advanced diagnostic platforms ensure that healthcare providers can offer accurate and timely results, significantly impacting patient outcomes in obstetrics and gynecology.

Abcam plc

Abcam plc is a leading supplier of protein research tools, providing a vast catalog of high-quality antibodies, reagents, and kits to the global life sciences community. In the lateral flow market, Abcam’s specialized antibodies and gold conjugation kits are essential for the development of high-performance rapid tests. By providing researchers and assay developers with reliable biological tools, Abcam supports the discovery of new biomarkers and the creation of sensitive diagnostic assays for various diseases and conditions.

Surmodics Inc.

Surmodics Inc. is a leading provider of surface modification technologies and in vitro diagnostic components. The company offers specialized chemical reagents and stabilized assay components that improve the sensitivity and performance of lateral flow assays. Surmodics’ focus on reducing non-specific binding and enhancing signal detection allows diagnostic manufacturers to produce more accurate and reliable rapid tests, supporting the development of next-generation diagnostic tools for complex clinical applications.

Chembio Diagnostics, Inc. (Biosynex)

Chembio Diagnostics, now part of Biosynex, is a leader in the development and manufacture of innovative rapid diagnostic tests for infectious diseases. The company is best known for its patented DPP (Dual Path Platform) technology, which offers superior sensitivity and multiplexing capabilities compared to traditional lateral flow assays. This advanced platform allows for the simultaneous detection of multiple pathogens from a single sample, making it a critical tool for the management of diseases such as HIV, syphilis, and various tropical illnesses.

OraSure Technologies

OraSure Technologies is a leader in the development and manufacture of oral fluid diagnostic products and specimen collection devices. The company’s flagship lateral flow product, the OraQuick In-Home HIV Test, revolutionized the market by providing a simple, non-invasive way for individuals to test themselves. OraSure focuses on expanding access to testing through user-friendly, high-accuracy diagnostic solutions for infectious diseases and substance abuse, empowering patients to take control of their health in both professional and home settings.

DCN Diagnostics

DCN Diagnostics is a specialized provider of contract development and manufacturing services for lateral flow assays. The company offers end-to-end solutions, from initial assay concept and feasibility studies to full-scale commercial production. With deep expertise in the engineering and optimization of rapid diagnostic tests, DCN Diagnostics serves as a critical partner for biotechnology companies and healthcare organizations looking to bring innovative lateral flow products to market across clinical, veterinary, and environmental applications.

Polysciences Inc.

Polysciences Inc. is a manufacturer of specialty chemicals, monomers, and polymers used in various industrial and laboratory applications. For the diagnostics industry, the company provides a range of high-quality particles and microspheres, including dyed and fluorescent beads, which are essential components for signal detection in lateral flow assays. Polysciences’ focus on precision manufacturing and material science supports the development of sensitive and reliable rapid diagnostic tests for a broad spectrum of medical and research uses.

Abingdon Health

Abingdon Health is a leading UK-based contract development and manufacturing organization (CDMO) specializing in lateral flow technology. The company provides comprehensive services for the rapid development and scale-up of diagnostic tests for human health, animal health, and environmental monitoring. Abingdon Health’s multidisciplinary team and automated manufacturing facilities enable the delivery of high-quality, cost-effective rapid testing solutions, helping clients accelerate the commercialization of new diagnostic products.

Oranoxis Inc.

Oranoxis Inc. is a manufacturer of rapid diagnostic products specializing in oral fluid drug testing and infectious disease screening. The company offers a range of lateral flow assays designed for use in professional, workplace, and forensic settings. Oranoxis focuses on providing reliable and easy-to-use testing solutions that deliver fast results, supporting the effective management of substance abuse programs and contributing to public health and safety through timely screening.

AESKU.GROUP GmbH

AESKU.GROUP GmbH is a global leader in autoimmune diagnostics, offering a comprehensive range of products from individual assays to fully automated laboratory systems. The company provides high-performance lateral flow tests for the rapid screening of autoimmune diseases and infectious pathogens. AESKU’s commitment to research and its integrated approach to diagnostics ensure that its rapid testing solutions provide clinicians with the accuracy and reliability needed for effective patient diagnosis and long-term condition monitoring.

Bio Group Medical System S.r.l.

Bio Group Medical System S.r.l. is an Italian manufacturer of in vitro diagnostic medical devices, focusing on rapid immunochromatographic tests. The company provides a diverse portfolio of lateral flow assays for the detection of infectious diseases, tumor markers, and hormones. Bio Group emphasizes quality and compliance with international standards, delivering reliable diagnostic tools to hospitals and private laboratories to support routine clinical screening and early disease detection.

PharmaCT GmbH

PharmaCT GmbH is a German-based company specializing in the development and distribution of innovative rapid diagnostic tests for professional and home use. The company offers a variety of lateral flow solutions, including tests for infectious diseases and metabolic health markers. PharmaCT focuses on delivering high-quality, user-friendly diagnostic products that provide fast and actionable results, helping healthcare providers and consumers monitor health status and manage diseases more effectively.

Diesse Diagnostica Senese S.p.A.

Diesse Diagnostica Senese S.p.A. is an Italian company dedicated to the development and production of innovative in vitro diagnostic systems. While known for its automated laboratory instrumentation, Diesse also provides specialized rapid tests based on immunochromatographic technology. The company’s focus on R&D and its commitment to quality allow it to offer reliable diagnostic solutions that meet the needs of clinical laboratories and point-of-care settings, particularly in the management of infectious and inflammatory conditions.

Xiamen Biotime Biotechnology Co., Ltd.

Xiamen Biotime Biotechnology Co., Ltd. is a Chinese high-tech enterprise specializing in the research, development, and manufacture of point-of-care testing (POCT) systems and reagents. The company offers an extensive range of lateral flow assays, including rapid tests for chronic diseases, infectious diseases, and cardiac markers. Biotime’s focus on technological innovation and its large-scale manufacturing capabilities allow it to provide cost-effective and reliable diagnostic tools to a broad range of global markets, supporting early disease screening and patient monitoring.

Download PDF Brochure:“Click Here”